TNBC is a very aggressive subtype of breast cancer due to its lack of the hormonal receptors as well as HER-2 and thus unresponsive to hormonal therapies such as ER/PR antagonists or trastuzumab therapies. The gene discussed is NR4A1; the disease is breast cancer.